Dominik Zalewski

Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration A Randomized Clinical Trial

2021 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové

Publication